Drug intelligence / Profile preview

Rp-8-Br-cAMPS-pAB

Development stage
Unknown
Lead developer
BIOLOG Life Science Institute
Modality
Small Molecules
01

Overview

Rp-8-Br-cAMPS-pAB (Rp-pAB) is a highly membrane-permeable, bioactivatable para-acetoxybenzyl (pAB) ester prodrug of the cyclic adenosine monophosphate (cAMP) antagonist Rp-8-Br-cAMPS. Developed as a pharmacological research tool, it is metabolized by ubiquitous cytosolic esterases to release the active free Rp-8-Br-cAMPS. Once bioactivated, it acts as a dual competitive antagonist of both protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac1 and Epac2). Rp-8-Br-cAMPS-pAB is widely used in laboratory research to investigate cAMP-dependent signaling pathways, particularly in pancreatic beta-cells where it has been shown to selectively inhibit first-phase glucose-stimulated insulin secretion (GSIS) and block GLP-1 receptor-mediated signaling.

Other names
8-bromoadenosine-3',5'-cyclic monophosphorothioate, Rp-isomer, 4-acetoxybenzyl esterRp-8-Br-cAMPS-pABRp8-Br-cAMPS-pABRp 8-Br-cAMPS-pABRp-pAB
02

Targets

EPAC1 (Rap guanine nucleotide exchange factor 3)EPAC2 (Rap guanine nucleotide exchange factor 4)PKA (Cyclic amp-dependent protein kinase)

Beyond the preview

Go deeper on Rp-8-Br-cAMPS-pAB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rp-8-Br-cAMPS-pAB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call